Factsheet and Information Brochure
Factsheet
Target Market
Costs and charges
Fund rules (136 kB)
Prospectus (1340 kB)
Periodic reports
Sustainability SFDR (924 kB)
Annual review (PF) (2879 kB)
Semi-annual report (PF) (189 kB)
Marketing material
Brief fund information
Summary SFDR (168 kB)
AstraZeneca Allemansfond
Legal name: AstraZeneca Allemansfond
Equity Fund Registered in Sweden (Non-UCITS)
Bid
About risk
Historical yields are not a guarantee of future returns. A fund can both increase and decrease in value and it is not guaranteed that you will recover the entire invested amount. Note that a fund with risk level 5-7, as stated in the fund's fact sheet (KID), can vary greatly in value due to the fund's composition and management methodology. The prospectus, fund rules and KID are available under each fund. Summary of investors' rights.
Objectives and Investment Policy
The fund is actively managed, which means that the portfolio manager takes active, independent investment decisions. The long term objective of the fund is to exceed the returns of the underlying market, defined as the benchmark index.
Fund returns are determined by how the fund's investments in equities increase or decrease in value. The fund is a special fund (non-UCITS) and thereby the fund deviates from a UCITS fund by concentrating holdings to a smaller number of equities issued by companies in primarily Sweden. The fund invests a significant amount (maximum of 50% of assets) in AstraZeneca.
International norms and guidelines for the environment, social responsibility and corporate governance are taken into consideration within the scope of the fund’s investment focus. The fund applies an exclusion strategy for companies operating within the fossil fuels, military equipment, tobacco, cannabis, alcohol, commercial gambling and pornography segments/sectors. However, the fund may invest in companies or funds that invest in companies involved in power generation, distribution or services related to fossil fuels in those cases where the company is deemed to be transitioning its operations to more renewable energy.
The fund may invest in derivative instruments as part of its investment focus. The fund may invest a maximum of 10% of the fund capital in fund units.
We compare the fund's performance with SIX SRI Sweden Index GI (60%), AstraZeneca (40%). As the fund is actively managed the performance will over time deviate from this index.
The fund does not distribute dividends. All income is reinvested in the fund. Normally, you may purchase and sell fund units every banking day.
Additional information about the sustainability work and the management in relation to the funds benchmark index and risk level, may be found in the prospectus.
Recommendation: This fund may not be suitable for investors who plan to withdraw their money within 5 years.
Performance
In percent including distribution
The bar chart above shows the fund’s historical performance in SEK, net of fees. If the fund pays dividends, performance is calculated with the distribution added back. Inflation has not been taken into account.
| Performance | Fund 1 | Index 2 |
|---|---|---|
| 31.10.2024 | 13.16 | 13.04 |
| 2023 | 11.88 | 11.49 |
| 2022 | 1.96 | -3.67 |
| 2021 | 38.98 | 37.20 |
| 2020 | 2.87 | 5.09 |
| Average. perf. | Fund 1 | Index 2 | 2 years | 16.26 | 15.64 |
|---|---|---|
| 3 years | 10.43 | 8.25 |
| 5 years | 14.03 | - |
| 10 years | 14.02 | - |
Sector Breakdown 31.10.2024
Largest holdings 31.10.2024
| AstraZeneca PLC | 42.72% |
| Volvo AB Class B | 5.99% |
| Assa Abloy AB Class B | 5.01% |
| Skandinaviska Enskilda Banken AB Class A | 4.50% |
| Hexagon AB Class B | 4.19% |
| Essity AB Class B | 3.61% |
| Sandvik AB | 3.21% |
| Beijer Ref AB Class B | 3.08% |
| ABB Ltd | 3.02% |
| Svenska Handelsbanken AB Class A | 2.97% |
Style Box™ 31.10.2024
Risk measures (3 years) 31.10.2024
| Total risk | 14.12% |
| Total risk in index | 14.10%* |
| Tracking error | 3.67%* |
| Information ratio | 0.59* |
| Sharpe ratio | 0.59 |
| Sharpe ratio index | 0.43* |
Distributions are reinvested in the funds and their benchmarks to obtain relevant comparisons. All key figures are calculated on the basis of effective annual yields. Values for the past three years have been used for the majority of funds. For newer funds Handelsbanken Fonder AB uses Bloomberg Port for risk forecast calculations.
Total risk/Total risk in index is stated as the standard deviation for variations in the fund/index's monthly yields. The higher the number, the higher the risk.
Tracking error is measured as the standard deviation for the difference between yields in the fund and its benchmark (variation in relative yields). The historical tracking error indicates how much the fund’s yield has deviated from its benchmark.
Information ratio is a measure of the active returns attained by the fund by deviating from its benchmark. It is the ratio between the active returns and the tracking error. A negative information ratio means that the fund has underperformed its benchmark.
Sharpe ratio/Sharpe ratio is a measure of the fund/index’s return, taking into account the risk of the fund/index. A high return attained at a lower risk is better than an equivalent return attained at a high risk. Calculated, on the one hand, as the ratio between the return, less the risk-free interest (interest on government securities) and, on the other hand, the total risk of the fund/index. The Sharpe ratio is most relevant to compare the yields of various markets, while taking risk into account.
Total risk/Total risk in index is stated as the standard deviation for variations in the fund/index's monthly yields. The higher the number, the higher the risk.
Tracking error is measured as the standard deviation for the difference between yields in the fund and its benchmark (variation in relative yields). The historical tracking error indicates how much the fund’s yield has deviated from its benchmark.
Information ratio is a measure of the active returns attained by the fund by deviating from its benchmark. It is the ratio between the active returns and the tracking error. A negative information ratio means that the fund has underperformed its benchmark.
Sharpe ratio/Sharpe ratio is a measure of the fund/index’s return, taking into account the risk of the fund/index. A high return attained at a lower risk is better than an equivalent return attained at a high risk. Calculated, on the one hand, as the ratio between the return, less the risk-free interest (interest on government securities) and, on the other hand, the total risk of the fund/index. The Sharpe ratio is most relevant to compare the yields of various markets, while taking risk into account.
Facts
| Fund Facts | |
|---|---|
| Fund managed by | Ulrika Orstadius |
| Country of registration | Sweden |
| Main category | Equity Fund |
| Sub category | Nordic |
| Fund, date of launch | 01.04.1984 |
| Share class, date of launch | 01.04.1984 |
| Fund assets | 4,737 MSEK (31.10.2024) |
| Reporting Currency | SEK |
| Trading Currency | - |
| Instrument category | Uncomplicated |
| UCITS | No |
| ISIN | SE0000900169 |
| Short name | ASTRA |
| Available for sale | Sweden |
| Fund Company Facts | |
|---|---|
| Management Company | Handelsbanken Fonder AB |
| Approval of fund operations | 06.05.1991 |
| Other approvals |
Discretionary Asset Management Manager of Alternative Investment Funds (AIFs) Provide investment advice Receive and forward orders
|
| Custodian Institution | J. P. Morgan SE - Stockholm Bankfilial |
| Legal domicile of fund | Stockholm, Sweden |
| Regulation Authority | Swedish Financial Supervisory Authority |
| Auditor | PricewaterhouseCoopers |
| Complaints Manager | Jörgen Larson |